Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events Published, JLR Papers in Press, November 8, 2006.

The relationship between autoantibodies to oxidized low density lipoprotein (OxLDL) and coronary artery disease (CAD) remains controversial. IgM and IgG OxLDL autoantibodies to malondialdehyde (MDA)-modified LDL, copper oxidized low density lipoprotein (CuOxLDL), and oxidized cholesterol linoleate (OxCL), as well as apolipoprotein B-100 immune complexes (apoB-ICs), were measured in 504 patients undergoing clinically indicated coronary angiography. Patients were followed for cardiovascular events for a median of 4 years. In univariate analysis, IgM OxLDL autoantibodies and IgM apoB-ICs were inversely associated with the presence of angiographically determined CAD, whereas IgG OxLDL autoantibodies and IgG apoB-ICs were positively associated. In logistic regression analysis, compared with the first quartile, patients in the fourth quartile of IgM OxLDL autoantibodies and apoB-ICs showed a lower probability of angiographically determined CAD (>50% diameter stenosis). Odds ratios and (95% confidence intervals) were as follows: MDA-LDL, 0.51 (0.32–0.82; P = 0.005); CuOxLDL, 0.63 (0.39–1.01; P = 0.05); OxCL, 0.63 (0.39–1.01; P = 0.05); and apoB-IC, 0.55 (0.34–0.88; P = 0.013). These relationships were accentuated in the setting of hypercholesterolemia, with the highest IgM levels showing the lowest risk of CAD for the same level of hypercholesterolemia. Multivariable analysis revealed that neither IgM or IgG OxLDL autoantibodies nor apoB-ICs were independently associated with angiographically determined CAD or cardiovascular events. In conclusion, IgG and IgM OxLDL biomarkers have divergent associations with CAD in univariate analysis but are not independent predictors of CAD or clinical events.

[1]  Qingbo Xu,et al.  Oxidized low-density lipoprotein autoantibodies, chronic infections, and carotid atherosclerosis in a population-based study. , 2006, Journal of the American College of Cardiology.

[2]  S. Tsimikas.  Oxidized low-density lipoprotein biomarkers in atherosclerosis , 2006, Current atherosclerosis reports.

[3]  M. Uusitupa,et al.  Antibodies against oxidized LDL and cardiolipin and mortality in patients with coronary heart disease. , 2005, Atherosclerosis.

[4]  E. Brilakis,et al.  Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. , 2005, The New England journal of medicine.

[5]  J. Witztum,et al.  Thematic review series: The Immune System and Atherogenesis. The role of natural antibodies in atherogenesis Published, JLR Papers in Press, May 16, 2005. DOI 10.1194/jlr.R500005-JLR200 , 2005, Journal of Lipid Research.

[6]  J. Witztum,et al.  The role of natural antibodies in atherogenesis. , 2005, Journal of lipid research.

[7]  E. Brilakis,et al.  Association of lipoprotein-associated phospholipase A2 levels with coronary artery disease risk factors, angiographic coronary artery disease, and major adverse events at follow-up. , 2005, European heart journal.

[8]  K. Lackner,et al.  Reduced In Vivo Aortic Uptake of Radiolabeled Oxidation-Specific Antibodies Reflects Changes in Plaque Composition Consistent With Plaque Stabilization , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[9]  Y. Shoenfeld,et al.  Are Anti–Oxidized Low-Density Lipoprotein Antibodies Pathogenic or Protective? , 2004, Circulation.

[10]  W. Sasiela,et al.  High-Dose Atorvastatin Reduces Total Plasma Levels of Oxidized Phospholipids and Immune Complexes Present on Apolipoprotein B-100 in Patients With Acute Coronary Syndromes in the MIRACL Trial , 2004, Circulation.

[11]  B. Strauss,et al.  Percutaneous Coronary Intervention Results in Acute Increases in Oxidized Phospholipids and Lipoprotein(a): Short-Term and Long-Term Immunologic Responses to Oxidized Low-Density Lipoprotein , 2004, Circulation.

[12]  Aldons J Lusis,et al.  Thematic review series: The Pathogenesis of Atherosclerosis Published, JLR Papers in Press, April 1, 2004. DOI 10.1194/jlr.R400001-JLR200 The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL , 2004, Journal of Lipid Research.

[13]  A. Pessina,et al.  Antibodies to Oxidized Low-Density Lipoproteins and Angiographically Assessed Coronary Artery Disease in White Patients , 2003, Circulation.

[14]  M. Päivänsalo,et al.  Immunoglobulin M Type of Autoantibodies to Oxidized Low-Density Lipoprotein Has an Inverse Relation to Carotid Artery Atherosclerosis , 2003, Circulation.

[15]  J. Witztum,et al.  Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL , 2003, Nature Medicine.

[16]  Joseph Juliano,et al.  Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes. , 2003, Journal of the American College of Cardiology.

[17]  H. Horiguchi,et al.  Oxidized LDL in Carotid Plaques and Plasma Associates With Plaque Instability , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[18]  C. Napoli,et al.  The fetal origins of atherosclerosis: maternal hypercholesterolemia, and cholesterol‐lowering or antioxidant treatment during pregnancy influence in utero programming and postnatal susceptibility to atherogenesis , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[19]  B. Fagerberg,et al.  Circulating Oxidized LDL Is Associated With Subclinical Atherosclerosis Development and Inflammatory Cytokines (AIR Study) , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[20]  A. Jaffe,et al.  Gender Differences in C-Reactive Protein Concentrations - Confirmation with Two Sensitive Methods , 2002, Clinical chemistry and laboratory medicine.

[21]  D. Rader,et al.  Absence of 12/15-Lipoxygenase Expression Decreases Lipid Peroxidation and Atherogenesis in Apolipoprotein E—Deficient Mice , 2001, Circulation.

[22]  J. Witztum,et al.  Measuring circulating oxidized low-density lipoprotein to evaluate coronary risk. , 2001, Circulation.

[23]  T. Matsuo,et al.  Elevated Levels of Oxidized Low Density Lipoprotein Show a Positive Relationship With the Severity of Acute Coronary Syndromes , 2001, Circulation.

[24]  J. Berliner,et al.  Evidence for a role of phospholipid oxidation products in atherogenesis. , 2001, Trends in cardiovascular medicine.

[25]  T. Inoue,et al.  Clinical significance of antibody against oxidized low density lipoprotein in patients with atherosclerotic coronary artery disease. , 2001, Journal of the American College of Cardiology.

[26]  Anders Hamsten,et al.  LDL Immunization Induces T-Cell–Dependent Antibody Formation and Protection Against Atherosclerosis , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[27]  B. Fagerberg,et al.  Antibodies to Oxidized LDL in Relation to Intima-Media Thickness in Carotid and Femoral Arteries in 58-Year-Old Subjectively Clinically Healthy Men , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[28]  J. Witztum,et al.  Circulating Autoantibodies to Oxidized LDL Correlate With Arterial Accumulation and Depletion of Oxidized LDL in LDL Receptor–Deficient Mice , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[29]  Y. Shoenfeld,et al.  Heat shock protein 60/65, beta 2-glycoprotein I and oxidized LDL as players in murine atherosclerosis. , 2000, Journal of autoimmunity.

[30]  K. Desser.  Molecular Basis of Cardiovascular Disease: A Companion to Braunwald's Heart Disease , 2000, Annals of Internal Medicine.

[31]  M. Uusitupa,et al.  Autoantibodies against oxidized low-density lipoprotein and cardiolipin in patients with coronary heart disease. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[32]  T. Lehtimäki,et al.  Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[33]  E. Miller,et al.  Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[34]  P. Shah,et al.  Immunization with homologous oxidized low density lipoprotein reduces neointimal formation after balloon injury in hypercholesterolemic rabbits. , 1997, Journal of the American College of Cardiology.

[35]  L. Niskanen,et al.  Autoantibodies against oxidized LDL do not predict atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[36]  J. Boer,et al.  Autoantibodies against MDA-LDL in subjects with severe and minor atherosclerosis and healthy population controls. , 1996, Atherosclerosis.

[37]  C. Rackley,et al.  Autoantibody titers to oxidized low-density lipoprotein in patients with coronary atherosclerosis. , 1996, American heart journal.

[38]  S. Young,et al.  Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[39]  J. Fruchart,et al.  Detection of autoantibodies against oxidized low-density lipoproteins and of IgG-bound low density lipoproteins in patients with coronary artery disease. , 1995, Clinica chimica acta; international journal of clinical chemistry.

[40]  E. Miller,et al.  Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[41]  L. Tenkanen,et al.  Antibody against oxidized low-density lipoprotein predicting myocardial infarction. , 1994, Archives of internal medicine.

[42]  D. Steinberg,et al.  Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[43]  R. Ross,et al.  The pathogenesis of atherosclerosis (first of two parts). , 1976, The New England journal of medicine.